Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Front Genet ; 13: 869210, 2022.
Article in English | MEDLINE | ID: mdl-35571021

ABSTRACT

Background: Epilepsy in childhood is a common and diverse neurological disorder. We conducted a genetic and phenotype analysis of a Chinese cohort of infants and children with epilepsy. Methods: We conducted a pedigree analysis of 260 Chinese patients with epilepsy onset during infancy or childhood by whole exome sequencing (WES). Results: Of the 260 probands analyzed, a genetic diagnosis was established in 135 patients. One-hundred eighty-eight phenotypes were detected in those 135 positive/likely positive patients, 106 patients had more than two phenotypes, and 67 patients had more than three phenotypes. A total of 142 variants of 81 genes were detected among the positive/likely positive patients. Among these 142 variants, of which 87 of 66 genes were novel. Conclusion: Our findings extend the variant spectrum of genes related to epilepsy. Our results will be useful for genetic testing and counseling for patients with epilepsy.

2.
Mol Genet Genomic Med ; 8(7): e1264, 2020 07.
Article in English | MEDLINE | ID: mdl-32342646

ABSTRACT

BACKGROUND: Benign childhood epilepsy with centrotemporal spikes (BECTS) or benign rolandic epilepsy is the most common epileptic syndrome in school-age children. Genetics is an important factor in BECTS pathogenesis, and <10 genes were associated with BECTS. This study aimed to identify novel genetic causes of BECTS. METHODS: We conducted whole-exome sequencing on a patient with BECTS and validated the findings by Sanger sequencing in a pedigree with three patients. RESULTS: CHRNA4 c.1007G>A was identified in three patients with BECTS in a pedigree. Carbamazepine, which should be carefully used in BECTS, was observed to be effective in the treatment of our atypical BECTS proband based on the molecular diagnosis of CHRNA4. CONCLUSION: This is the first study on CHRNA4 variant in BECTS, which widened the genetic spectrum of BECTS and contributed to precise medicine in BECTS.


Subject(s)
Epilepsy, Rolandic/genetics , Mutation , Receptors, Nicotinic/genetics , Adult , Anticonvulsants/administration & dosage , Anticonvulsants/therapeutic use , Carbamazepine/administration & dosage , Carbamazepine/therapeutic use , Child , Child, Preschool , Epilepsy, Rolandic/diagnosis , Epilepsy, Rolandic/drug therapy , Female , Humans , Male , Pedigree , Precision Medicine/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...